NOX — Noxopharm Share News
0.000.00%
Last trade - 00:00- AU$26.30m
- AU$30.46m
- AU$2.83m
Australia Stock Exchange release from NOXOPHARM : Veyonda Achieves Important U.S. Patent Claims
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 10:07:56
Australia Stock Exchange release from NOXOPHARM : Noxopharm 2021 Annual Report
Australia Stock Exchange release from NOXOPHARM : Noxopharm Updated Corporate Presentation
Australia Stock Exchange release from NOXOPHARM : Change of Registered Office and Principal Place of Business
Australia Stock Exchange release from NOXOPHARM : Appendix 4E and Audited Financial Statements
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 17:49:28
Australia Stock Exchange release from NOXOPHARM : Appendix 4G and Corporate Governance Statement
Brief: Noxopharm Phase I Clinical Trial Shows Anti-Inflammatory Response In Covid-19 Patients
Noxopharm surges 13% as anti-inflammatory drug effective in COVID-19 patients
Australia Stock Exchange release from NOXOPHARM : Cleansing Notice
Australia Stock Exchange release from NOXOPHARM : Application for quotation of securities - NOX
Brief: Noxopharm Says Noxcovid Clinical Program To Expand Following Positive Phase 1 Clinical Results
Australia Stock Exchange release from NOXOPHARM : Pre-clinical Data Supports a Role for Veyonda in COVID-19
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 10:56:07
Australia Stock Exchange release from NOXOPHARM : NOXCOVID Program to Expand After Positive Phase 1 Results
Australia Stock Exchange release from NOXOPHARM : PRE_NR Ends: 09:44:16
Brief: Noxopharm Ltd Seeks Trading Halt
Australia Stock Exchange release from NOXOPHARM : Trading Halt